Geode Capital Management LLC Has $101.84 Million Holdings in Indivior PLC $INDV

Geode Capital Management LLC lessened its stake in shares of Indivior PLC (NASDAQ:INDV) by 0.7% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 2,837,824 shares of the company’s stock after selling 18,607 shares during the quarter. Geode Capital Management LLC’s holdings in Indivior were worth $101,840,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Quarry LP acquired a new stake in Indivior during the 3rd quarter worth about $26,000. Raymond James Financial Inc. purchased a new position in Indivior during the 2nd quarter valued at about $26,000. Salomon & Ludwin LLC purchased a new position in Indivior during the 4th quarter valued at about $30,000. Harbor Capital Advisors Inc. grew its stake in Indivior by 309.9% during the 4th quarter. Harbor Capital Advisors Inc. now owns 1,033 shares of the company’s stock valued at $37,000 after acquiring an additional 781 shares in the last quarter. Finally, GAMMA Investing LLC grew its stake in Indivior by 544.6% during the 4th quarter. GAMMA Investing LLC now owns 1,199 shares of the company’s stock valued at $43,000 after acquiring an additional 1,013 shares in the last quarter. Institutional investors and hedge funds own 60.33% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Weiss Ratings cut Indivior from a “hold (c+)” rating to a “hold (c)” rating in a research note on Wednesday, May 6th. Zacks Research raised Indivior from a “hold” rating to a “strong-buy” rating in a research note on Monday, March 16th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $39.33.

Indivior Price Performance

NASDAQ:INDV opened at $37.62 on Friday. Indivior PLC has a fifty-two week low of $13.42 and a fifty-two week high of $41.00. The stock’s 50-day moving average is $34.61 and its two-hundred day moving average is $34.10. The stock has a market cap of $4.59 billion, a PE ratio of 19.29 and a beta of 0.88.

Indivior (NASDAQ:INDV) last announced its quarterly earnings results on Tuesday, March 31st. The company reported $0.96 earnings per share (EPS) for the quarter. The business had revenue of $317.00 million during the quarter. Indivior had a negative return on equity of 219.26% and a net margin of 19.44%. On average, equities research analysts anticipate that Indivior PLC will post 4.05 earnings per share for the current year.

Indivior Profile

Indivior plc is a specialty pharmaceutical company dedicated to developing and delivering treatments for addiction and related mental health disorders. The company’s portfolio centers on therapies designed to support individuals dealing with opioid dependence, alcohol use disorder and other behavioral health challenges. Its lead products include Suboxone® (buprenorphine and naloxone) sublingual film and Sublocade® (extended-release buprenorphine) injection, both of which are approved in multiple markets to aid in opioid use disorder management.

Indivior was established in 2014 through a demerger from the pharmaceuticals division of Reckitt Benckiser Group plc, inheriting decades of research and commercial expertise in addiction medicine.